Ethinyl Estradiol
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
Line 5: | Line 5: | ||
'''KEGG PATHWAY'''(C07534,D00554) | '''KEGG PATHWAY'''(C07534,D00554) | ||
- | '''Category''' Hormone | + | |
+ | '''Category''' Hormone | ||
+ | |||
'''Activity''' Estrogen | '''Activity''' Estrogen | ||
+ | |||
{| border="1;width:100%; height:200px;style=text-align:center" | {| border="1;width:100%; height:200px;style=text-align:center" | ||
|+'''Table I:''' | |+'''Table I:''' | ||
Line 18: | Line 21: | ||
|Melting Point | |Melting Point | ||
|183 | |183 | ||
- | |deg C | + | |deg C |
- | + | ||
|EXP | |EXP | ||
|- | |- | ||
|log P (octanol-water) | |log P (octanol-water) | ||
|3.67 | |3.67 | ||
- | |(none) | + | |(none) |
- | + | ||
|EXP | |EXP | ||
|- | |- | ||
Line 53: | Line 54: | ||
|- | |- | ||
|} | |} | ||
- | Organism | + | {| border="1;width:100%; height:200px;style=text-align:center" |
- | mouse LD50 intraperitoneal 250mg/kg (250mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | + | |+'''Table I:''' |
+ | |- | ||
+ | ! style="background:brown; color:white" |Organism | ||
+ | ! style="background:brown; color:white" |Test Type | ||
+ | ! style="background:brown; color:white" |Route | ||
+ | ! style="background:brown; color:white" |Reported Dose (Normalized Dose) | ||
+ | ! style="background:brown; color:white" |Effect | ||
+ | ! style="background:brown; color:white" |Source | ||
+ | |- | ||
+ | |mouse | ||
+ | |LD50 | ||
+ | |intraperitoneal | ||
+ | |250mg/kg (250mg/kg) | ||
+ | |BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | ||
BEHAVIORAL: ATAXIA | BEHAVIORAL: ATAXIA | ||
- | + | KIDNEY, URETER, AND BLADDER: OTHER CHANGES | |
- | KIDNEY, URETER, AND BLADDER: OTHER CHANGES Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. | + | |Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. |
- | mouse LD50 oral 950mg/kg (950mg/kg) | + | |- |
- | mouse LD50 subcutaneous > 3gm/kg (3000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | + | |mouse |
- | + | |LD50 | |
- | BLOOD: HEMORRHAGE Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. | + | |oral |
- | rat LD50 intraperitoneal 471mg/kg (471mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | + | |950mg/kg (950mg/kg) |
+ | | | ||
+ | |Drugs in Japan Vol. -, Pg. 222, 1995. | ||
+ | |- | ||
+ | |mouse | ||
+ | |LD50 | ||
+ | |subcutaneous | ||
+ | |> 3gm/kg (3000mg/kg) | ||
+ | |BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | ||
+ | |BLOOD: HEMORRHAGE Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. | ||
+ | |- | ||
+ | |rat | ||
+ | |LD50 | ||
+ | |intraperitoneal | ||
+ | |471mg/kg (471mg/kg) | ||
+ | |BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | ||
BEHAVIORAL: ATAXIA | BEHAVIORAL: ATAXIA | ||
+ | KIDNEY, URETER, AND BLADDER: OTHER CHANGES | ||
+ | |Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. | ||
+ | |- | ||
+ | |rat | ||
+ | |LD50 | ||
+ | |oral | ||
+ | |960mg/kg (960mg/kg) | ||
+ | | | ||
+ | |Drugs in Japan Vol. -, Pg. 222, 1995. | ||
+ | |- | ||
+ | |rat | ||
+ | |LD50 | ||
+ | |subcutaneous | ||
+ | |> 2gm/kg (2000mg/kg) | ||
+ | |BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | ||
- | + | BLOOD: HEMORRHAGE | |
- | + | |Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. | |
- | + | |- | |
+ | |women | ||
+ | |TDLo | ||
+ | |oral | ||
+ | |21mg/kg/21D-I (21mg/kg) | ||
+ | |LUNGS, THORAX, OR RESPIRATION: DYSPNEA | ||
- | + | GASTROINTESTINAL: NAUSEA OR VOMITING | |
- | + | |Lancet. Vol. 1, Pg. 1479, 1973. | |
- | + | |- | |
- | GASTROINTESTINAL: NAUSEA OR VOMITING Lancet. Vol. 1, Pg. 1479, 1973. | + | |} |
- | + |
Revision as of 08:50, 24 October 2008
Ethinyl Estradiol Pubchem(5991)
A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.
KEGG PATHWAY(C07534,D00554)
Category Hormone
Activity Estrogen
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
Melting Point | 183 | deg C | EXP | |
log P (octanol-water) | 3.67 | (none) | EXP | |
Water Solubility | 11.3 | mg/L | 27 | EXP |
Vapor Pressure | 2.67E-09 | mm Hg | 25 | EST |
Henry's Law Constant | 7.94E-12 | atm-m3/mole | 25 | EST |
Atmospheric OH Rate Constant | 1.25E-10 | cm3/molecule-sec | 25 | EST |
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 250mg/kg (250mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: ATAXIA KIDNEY, URETER, AND BLADDER: OTHER CHANGES | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. |
mouse | LD50 | oral | 950mg/kg (950mg/kg) | Drugs in Japan Vol. -, Pg. 222, 1995. | |
mouse | LD50 | subcutaneous | > 3gm/kg (3000mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | BLOOD: HEMORRHAGE Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. |
rat | LD50 | intraperitoneal | 471mg/kg (471mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: ATAXIA KIDNEY, URETER, AND BLADDER: OTHER CHANGES | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. |
rat | LD50 | oral | 960mg/kg (960mg/kg) | Drugs in Japan Vol. -, Pg. 222, 1995. | |
rat | LD50 | subcutaneous | > 2gm/kg (2000mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BLOOD: HEMORRHAGE | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990. |
women | TDLo | oral | 21mg/kg/21D-I (21mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA
GASTROINTESTINAL: NAUSEA OR VOMITING | Lancet. Vol. 1, Pg. 1479, 1973. |